• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

repros

  1. A bad move by Allergan

    I don't know why Allergan is buying this struggling penny stock company. I don't think Allergan can do what Repros couldn’t and deliver the safety data that the FDA is looking for.